Potential Drug Recall


HPS Pharmacies wish to advise that the Therapeutic Goods Administration (TGA) has given notice of a potential drug recall of:

Provive® MCT-LCT 1% injection vial

Contents Propofol 200mg/20mL
Aust R 162318
Batch Nos. A030906 and A030907
Expiry 08/15


This notice has been issued due to a potential contamination of these specific batches of Provive® MCT-LCT 1% injection vial with the bacteria Ralstonia pickettii.

Contamination with R. pickettii may result in bacteraemia/septicaemia from this opportunistic Gram-negative bacillus.

No other batches or presentations of Provive® are affected by this recall, including Provive® 1% 200mg/20mL injection vial (Aust R 118938).

Please inspect your stocks and quarantine all units from the above batches at your premises. Further advice will be issued when details are known, at which time stock may be returned to use, or returned to your supplier.

Retain this notice in a prominent position, including in other related business units for one month in case stock is in transit. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates